OBJECTIVES: To evaluate the effect of functional overloading on the transplantation of muscle derived stem cells (MDSCs) into dystrophic muscle and the ability of transplanted cells to increase dystrophic muscle's ability to resist overloading-induced weakness. DESIGN: Cross-sectional. SETTING: Laboratory. ANIMALS: Male mice (N=10) with a dystrophin gene mutation. INTERVENTIONS: MDSCs were intramuscularly transplanted into the extensor digitorum longus muscle (EDL). Functional overloading of the EDL was performed by surgical ablation of the EDL's synergist. MAIN OUTCOME MEASURES: The total number of dystrophin-positive fibers/cross-section (as a measure of stem cell engraftment), the average number of CD31+ cells (as a measure of capillarity), and in vitro EDL contractile strength. Independent t tests were used to investigate the effect of overloading on engraftment, capillarity, and strength. Paired t tests were used to investigate the effect of MDSC engraftment on strength and capillarity. RESULTS: MDSC transplantation protects dystrophic muscles against overloading-induced weakness (specific twitch force: control 4.5N/cm2+/-2.3; MDSC treated 7.9N/cm2+/-1.4) (P=.02). This improved force production following overloading is concomitant with an increased regeneration by transplanted MDSCs (MDSC: 26.6+/-20.2 dystrophin-positive fibers/cross-section; overloading + MDSC: 170.6+/-130.9 dystrophin-positive fibers/cross-section [P=.03]). Overloading-induced increases in skeletal muscle capillarity is significantly correlated with increased MDSC engraftment (R2=.80, P=.01). CONCLUSIONS: These findings suggest that the functional contribution of transplanted MDSCs may rely on activity-dependent mechanisms, possibly mediated by skeletal muscle vascularity. Rehabilitation modalities may play an important role in the development of stem cell transplantation strategies for the treatment of muscular dystrophy.
OBJECTIVES: To evaluate the effect of functional overloading on the transplantation of muscle derived stem cells (MDSCs) into dystrophic muscle and the ability of transplanted cells to increase dystrophic muscle's ability to resist overloading-induced weakness. DESIGN: Cross-sectional. SETTING: Laboratory. ANIMALS: Male mice (N=10) with a dystrophin gene mutation. INTERVENTIONS: MDSCs were intramuscularly transplanted into the extensor digitorum longus muscle (EDL). Functional overloading of the EDL was performed by surgical ablation of the EDL's synergist. MAIN OUTCOME MEASURES: The total number of dystrophin-positive fibers/cross-section (as a measure of stem cell engraftment), the average number of CD31+ cells (as a measure of capillarity), and in vitro EDL contractile strength. Independent t tests were used to investigate the effect of overloading on engraftment, capillarity, and strength. Paired t tests were used to investigate the effect of MDSC engraftment on strength and capillarity. RESULTS: MDSC transplantation protects dystrophic muscles against overloading-induced weakness (specific twitch force: control 4.5N/cm2+/-2.3; MDSC treated 7.9N/cm2+/-1.4) (P=.02). This improved force production following overloading is concomitant with an increased regeneration by transplanted MDSCs (MDSC: 26.6+/-20.2 dystrophin-positive fibers/cross-section; overloading + MDSC: 170.6+/-130.9 dystrophin-positive fibers/cross-section [P=.03]). Overloading-induced increases in skeletal muscle capillarity is significantly correlated with increased MDSC engraftment (R2=.80, P=.01). CONCLUSIONS: These findings suggest that the functional contribution of transplanted MDSCs may rely on activity-dependent mechanisms, possibly mediated by skeletal muscle vascularity. Rehabilitation modalities may play an important role in the development of stem cell transplantation strategies for the treatment of muscular dystrophy.
Authors: Hideki Oshima; Thomas R Payne; Kenneth L Urish; Tetsuro Sakai; Yiqun Ling; Burhan Gharaibeh; Kimimasa Tobita; Bradley B Keller; James H Cummins; Johnny Huard Journal: Mol Ther Date: 2005-08-25 Impact factor: 11.454
Authors: E Bonilla; C E Samitt; A F Miranda; A P Hays; G Salviati; S DiMauro; L M Kunkel; E P Hoffman; L P Rowland Journal: Cell Date: 1988-08-12 Impact factor: 41.582
Authors: Mariz Vainzof; Danielle Ayub-Guerrieri; Paula C G Onofre; Poliana C M Martins; Vanessa F Lopes; Dinorah Zilberztajn; Lucas S Maia; Karen Sell; Lydia U Yamamoto Journal: J Mol Neurosci Date: 2008-01-18 Impact factor: 3.444
Authors: Fabrisia Ambrosio; Steven L Wolf; Anthony Delitto; G Kelley Fitzgerald; Stephen F Badylak; Michael L Boninger; Alan J Russell Journal: Phys Ther Date: 2010-10-28
Authors: Fabrisia Ambrosio; Michael L Boninger; Clifford E Brubaker; Anthony Delitto; William R Wagner; Richard K Shields; Steven L Wolf; Thomas A Rando Journal: J Rehabil Res Dev Date: 2013
Authors: Kristen M Stearns-Reider; Antonio D'Amore; Kevin Beezhold; Benjamin Rothrauff; Loredana Cavalli; William R Wagner; David A Vorp; Alkiviadis Tsamis; Sunita Shinde; Changqing Zhang; Aaron Barchowsky; Thomas A Rando; Rocky S Tuan; Fabrisia Ambrosio Journal: Aging Cell Date: 2017-03-30 Impact factor: 9.304
Authors: Giovanna Distefano; Ricardo Jose Ferrari; Christopher Weiss; Bridget M Deasy; Michael L Boninger; G Kelley Fitzgerald; Johnny Huard; Fabrisia Ambrosio Journal: PLoS One Date: 2013-03-19 Impact factor: 3.240